This challenge focused on improving protocol review through more digital, standards-based, and user-centric approaches—helping clinical teams assess feasibility, quality, risk, and burden earlier and more efficiently.

Nurocor was selected as the best integrated protocol authoring and review solution. The judges felt Nurocor stood out for a digital-first approach on a clinical workflow platform based on the USDM standard, with Word-like editing and commenting, section locking, and amendment impact analysis.

Industry collaboration drives meaningful innovation. Regeneron, BMS, IQVIA, and Nurocor have joined forces to demonstrate the power of collective action—using protocol and schedule of events (SOE) digitalization to dramatically streamline clinical trial setup and elevate quality standards. Together, we’re transforming how protocols are digitalized, creating a centralized source of truth for the sample journey that eliminates manual data entry, automates lab setup, and simplifies sample reconciliation across clinical trials.

Once traditional documents (protocol, SAP, operational plans) are in a fine-grained and semantically specified digital form, their content becomes actionable. TransCelerate Biopharma refers to this digitalization process as “breaking the document paradigm.” This means the content originally “locked up” in a document can be actively shared and easily reused. Processes can be redesigned to take full advantage of the power of digitalization, allowing cycle times to be considerably shortened. The Nurocor Lean Protocol™ process coupled with Nurocor Clinical Platform technology enables our customers to realize the full value of digitalization.